fda drug shortages semaglutide injection resolved date 2025 clarifies policies for compounders as national GLP-1 supply begins to stabilize FDA removes semaglutide from drug

Emerging research suggests GLP-1 receptor agonists may reduce inflammatory markers such as C-reactive protein and pro-inflammatory cytokines, though dedicated clinical trials examining low-dose regimens specifically for inflammation are lacking

But many are unaware of exactly what causes this increased risk, and why it has to do with insulin

Impeccable sleep hygiene provides the foundation for daytime energy

They may think theyre taking a gentle, all-natural weight-loss remedy with lots of traditional uses

CDCA was shown to be a high-affinity FXR agonist synthesized in the liver (Makishima et al., 1999), whereas CDCA was derived from CDCA and had different configurations and functions

OZEMPIC (semaglutide) injection, for subcutaneous use